Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
This article was originally published in The Tan Sheet
Executive Summary
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
You may also be interested in...
FDA Budget Proposal Shifts More Toward User Fees Reliance
User fees make up the bulk of FDA’s human drug spending under President Obama’s fiscal 2014 budget proposal, a trend fueled by new user fee programs and cuts to taxpayer funding.
FDA Budget Proposal Shifts More Toward User Fees Reliance
User fees make up the bulk of FDA’s human drug spending under President Obama’s fiscal 2014 budget proposal, a trend fueled by new user fee programs and cuts to taxpayer funding.
FDA IT Systems In Senate Appropriators’ Crosshairs
The Senate Appropriations Committee approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in direct funding over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs.